Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer

Chenxi Yin,1,2,* Chang Jiang,1,2,* Fangxin Liao,1,2 Yuming Rong,1,2 Xiuyu Cai,1,2 Guifang Guo,1,2 Huijuan Qiu,1,2 Xuxian Chen,1,2 Bei Zhang,1,2 Wenzhuo He,1,2 Liangping Xia1,2 1State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center f...

Full description

Bibliographic Details
Main Authors: Yin CX, Jiang C, Liao FX, Rong YM, Cai XY, Guo GF, Qiu HJ, Chen XX, Zhang B, He WZ, Xia LP
Format: Article
Language:English
Published: Dove Medical Press 2014-08-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/initial-ldh-level-can-predict-the-survival-benefit-from-bevacizumab-in-peer-reviewed-article-OTT

Internet

http://www.dovepress.com/initial-ldh-level-can-predict-the-survival-benefit-from-bevacizumab-in-peer-reviewed-article-OTT

Similar Items